Evidence map›Paper›PMID 41383861›Full record

ArticleClinical ophthalmology (Auckland, N.Z.)2025

Structural and Functional Outcomes of Optic Pathway Compression in Pituitary Adenoma: A Prospective Pilot OCT Study.

Michal Březík, Jan Němčanský, Tomáš Krejčí, Ondřej Polách, Juraj Timkovič, Oldřich Chrapek

Abstract read
In one paragraph

Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Michal BřezíkClinic of Ophthalmology, University Hospital Ostrava, Ostrava, Czech Republic.ORCID 0009-0009-2104-6618
Jan NěmčanskýClinic of Ophthalmology, University Hospital Ostrava, Ostrava, Czech Republic.
Tomáš KrejčíClinic of Neurosurgery, University Hospital Ostrava, Ostrava, Czech Republic.
Ondřej PoláchClinic of Ophthalmology, University Hospital Ostrava, Ostrava, Czech Republic.
Juraj TimkovičClinic of Ophthalmology, University Hospital Ostrava, Ostrava, Czech Republic.ORCID 0000-0003-0767-0552
Oldřich ChrapekDepartment of Ophthalmology, Faculty of Medicine Masaryk University, Brno, Czech Republic.ORCID 0000-0002-1403-4936

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To evaluate the anatomical and functional effects of optic chiasm compression caused by a pituitary adenoma both before and after surgery. Patients and Methods: Short-term prospective study of 48 eyes from 24 patients who underwent radical surgery for pituitary adenoma. Comprehensive ophthalmological assessment was performed and OCT (optical coherence tomography) parameters (RNFL - retinal nerve fiber layer, GCL - ganglion cell layer, BMO-MRW - Bruch's membrane opening-minimum rim width) and BVCA (best corrected visual acuity) using ETDRS (Early Treatment Diabetic Retinopathy Study) chart were evaluated before surgery and 3 months after surgery. Results: Over time, a decline in RNFL was observed in circular scans of 3.5 mm, 4.1 mm, and 4.7 mm (p = 0.001-0.04), as well as in GCL (p = 0.001-0.022) and BMO-MRW (p = 0.001-0.033). The median improvement in vision was 4 letters (IQR 0-6) (p < 0.001). A positive correlation between RNFL and visual improvement was found only in the TS (temporo-superior) sector in the 4.7 mm circle (p = 0.018). A negative correlation was observed between the difference between preoperative and normative RNFL and GCL values and the postoperative BCVA (RNFL p = 0.005-0.046, GCL p = 0.009-0.022). Conclusion: Following radical surgery all three OCT parameters show a significant decline. While the reduction between preoperative and postoperative values does not influence the final visual outcome, preoperative atrophy of the RNFL and the GCL is negatively correlated with postoperative BCVA. The BMO-MRW may represent a novel marker of compressive neuropathy.

Indexed as

BMO-MRWETDRSGCLRNFL

Identifiers

PMID41383861
PMCPMC12691600

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.